The chemical class known as AQP12B activators encompasses a diverse array of compounds that can influence the activity of the aquaporin 12B (AQP12B) protein, a member of the larger family of aquaporins involved in cellular water transport mechanisms. These activators are not direct ligands binding to the protein in a lock-and-key fashion, but rather function through intricate cellular signaling pathways to modulate the activity of AQP12B. The regulation of aquaporin activity is a complex process, typically involving changes in gene expression, protein trafficking to the cell membrane, and modifications of the protein structure through phosphorylation or other post-translational modifications. The compounds in this class can activate adenylate cyclase or inhibit phosphodiesterases, leading to an increase in intracellular cyclic AMP (cAMP), which, in turn, activates protein kinase A (PKA). PKA can then phosphorylate aquaporins, influencing their distribution and function within the cell.
Additionally, this class includes compounds that alter the phosphorylation status of the protein indirectly through their effects on protein phosphatases such as PP1 and PP2A. By inhibiting these phosphatases, the phosphorylated state of AQP12B, which may be critical for its function, is maintained. Other members of this class can activate protein kinase C (PKC), which also phosphorylates target proteins, including aquaporins, and affects their cellular localization or function. Moreover, compounds that disrupt cellular ion balance can influence the activity of AQP12B. By altering the ion gradients across the cell membrane, these activators can cause cellular events that lead to changes in the volume regulation mechanisms where AQP12B plays a role. Ionophores, for example, form complexes with specific ions and facilitate their transport across cell membranes, disrupting the ionic equilibrium and possibly affecting AQP12B activity. The collective actions of these compounds, through their respective pathways, culminate in the modulation of AQP12B activity, affecting water transportation dynamics within cells.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels in cells, which can lead to the activation of PKA. PKA could possibly activate AQP12B by affecting its trafficking or gating. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
Isobutylmethylxanthine (IBMX) is a non-selective inhibitor of phosphodiesterases (PDEs), which would prevent cAMP breakdown, potentially enhancing PKA activity that could possibly activate AQP12B. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates protein kinase C (PKC), which could possibly activate AQP12B by phosphorylating the channel or associated proteins, affecting their localization or function. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $160.00 $750.00 | 59 | |
Calyculin A is a potent inhibitor of protein phosphatases 1 (PP1) and 2A (PP2A), which could possibly activate AQP12B by preventing its dephosphorylation, affecting activity or localization. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
Okadaic acid is a potent inhibitor of PP1 and PP2A, which could possibly activate AQP12B by altering its phosphorylation status. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Genistein is a tyrosine kinase inhibitor, which could possibly activate AQP12B by affecting cellular signaling pathways involved in aquaporin regulation. | ||||||
Valinomycin | 2001-95-8 | sc-200991 | 25 mg | $163.00 | 3 | |
Valinomycin is a potassium ionophore, which could possibly activate AQP12B by altering cellular ion balance and affecting related signaling pathways. | ||||||
Ouabain-d3 (Major) | sc-478417 | 1 mg | $506.00 | |||
Ouabain is an inhibitor of the Na+/K+-ATPase pump, which could possibly activate AQP12B by altering cellular ion homeostasis and potentially influencing expression or trafficking. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
Brefeldin A disrupts the Golgi apparatus and could possibly activate AQP12B by affecting protein trafficking, potentially influencing the cellular distribution of aquaporins. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $152.00 $515.00 | ||
Monensin is an ionophore that disrupts intracellular ion gradients; it could possibly activate AQP12B by altering cell volume or osmoregulation. | ||||||